Toggle Nav
Search
Advanced Search
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research-area stem-cell hippo-signaling'

Search results for: 'research-area stem-cell hippo-signaling'

Shop By
Clear All

Items 1-10 of 30

Page
per page
  1. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
      ≥2.74 mg/mL
      insoluble in h2o
  2. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
      ≥7.97 mg/mL
      insoluble in h2o
  3. CAL-101 (Idelalisib, GS-1101)
    A3005 CAL-101 (Idelalisib, GS-1101)
     2 Citation
    Target: PI3K
    Summary: PI3K inhibitor
      ≥80.2 mg/mL
      ≥2.1 mg/mL
      insoluble in h2o
  4. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1/PKA/CDK2 inhibitor,potent and selective
      ≥4.9 mg/mL
  5. BYL-719
    A8346 BYL-719
     1 Citation
    Target: PI3K
    Summary: Selective PI3Kα inhibitor
      ≥22.1 mg/mL
  6. BIX 02189
    A5801 BIX 02189
    Target: MEK|ERK
    Summary: Selective MEK5 inhibitor
      ≥22.05 mg/mL
      ≥40.7 mg/mL
      insoluble in h2o
  7. AZD6482
    A5478 AZD6482
    Target: PI3K
    Summary: PI3Kβ inhibitor,potent and selective
      ≥20.4 mg/mL
      ≥6.36 mg/mL
      insoluble in h2o
  8. AS-605240
    A5176 AS-605240
    Target: PI3K
    Summary: Potent and selective PI 3-Kγ inhibitor
      ≥4.28 mg/mL
      insoluble in etoh
      insoluble in h2o
  9. TG100-115
    A2754 TG100-115
    Target: PI3K
    Summary: PI3Kγ/PI3Kδ inhibitor
      ≥3.46 mg/mL
  10. TGX-221
    A2681 TGX-221
    Target: PI3K
    Summary: PI3Kβ inhibitor,potent,selective and ATP competitive
      ≥68.7 mg/mL

Items 1-10 of 30

Page
per page
Shop By
Now Shopping by
  1. Target ERK Remove This Item
  2. Target TRPC channel Remove This Item
  3. Target PI3K Remove This Item
  4. Target Raf Remove This Item
Clear All
Shopping Options
Category
Specificity
  1. Selective 22 items
  2. Non-Selective 1 item
Reversibility
  1. Reversible 1 item
Target
  1. Caspases 8 items
  2. Cyclin-Dependent Kinases 18 items
  3. Proteasome 7 items
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 16 items
  6. Inhibitor of apoptosis proteins (IAP) 1 item
  7. Akt 9 items
  8. Bcl-2 2 items
  9. PI3K 17 items
  10. Raf 9 items
  11. Aurora Kinases 6 items
  12. Bcl-xl 1 item
  13. Glycoproteins 1 item
  14. MDM2 1 item
  15. EZH2 3 items
  16. mTOR 9 items
  17. Bromodomains 1 item
  18. AP-1 2 items
  19. MMP 1 item
  20. Androgen Receptors 1 item
  21. Myosin II ATPases 1 item
  22. FLT3 2 items
  23. GSK-3 8 items
  24. LPA Receptors 1 item
  25. P-glycoprotein (P-gp) 3 items
  26. PLK 7 items
  27. Chk 4 items
  28. VEGFR 7 items
  29. PDGFR 4 items
  30. c-Kit 1 item
  31. Bromodomain-containing proteins(BRDs) 1 item
  32. Phosphodiesterases (PDEs) 2 items
  33. Hydrolase 1 item
  34. p38 4 items
  35. PKB 1 item
  36. JNK 4 items
  37. Bcr-Abl 1 item
  38. MEK 7 items
  39. PORCN 1 item
  40. DOT1L 1 item
  41. FGFR 3 items
  42. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  43. Sir2-like Family Deacetylases (Sirtuins) 1 item
  44. Deubiquitinating enzymes (DUBs) 1 item
  45. Smoothened 2 items
  46. Ras 1 item
  47. Src 2 items
  48. Trk Receptors 2 items
  49. STAT 8 items
  50. Microtubules/Tubulins 4 items
  51. Estrogen and Related Receptors 1 item
  52. EGFR 8 items
  53. Hedgehog 1 item
  54. Reverse Transcriptases 1 item
  55. ROCK 7 items
  56. FAK 4 items
  57. BMP and Other Activin Receptors 2 items
  58. JAK 5 items
  59. p300 1 item
  60. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  61. Syk 1 item
  62. DNA-PK 3 items
  63. HSP90 1 item
  64. AMPK 2 items
  65. CCR 1 item
  66. CFTR 3 items
  67. TNKS 1 item
  68. Cytochrome P450 (CYP450) 1 item
  69. ErbB 2 items
  70. Toll-like receptors (TLRs) 2 items
  71. Actin 1 item
  72. DNA Methyltransferases 1 item
  73. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  74. ERK 3 items
  75. BMI-1 1 item
  76. PKC 10 items
  77. Calpains 1 item
  78. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2 items
  79. Lyn 1 item
  80. SGLT 1 item
  81. RAD51 1 item
  82. Pyk2 3 items
  83. USP 1 item
  84. LRRK2 2 items
  85. Voltage-gated Calcium Channels (CaV) 1 item
  86. Insulin and Insulin-like Receptors 1 item
  87. ALK 4 items
  88. Sphingosine kinases (SphKs) 1 item
  89. GTPases 1 item
  90. PKG 1 item
  91. PKA 6 items
  92. D2 Receptors 1 item
  93. Fatty-acid-binding proteins (FABPs) 1 item
  94. Tie-2 1 item
  95. RSK 1 item
  96. Granzyme B 1 item
  97. Free Fatty Acid Receptors 1 item
  98. phosphatases 1 item
  99. Autophagy 2 items
  100. ATM/ATR 5 items
  101. CK1 1 item
  102. Farnesyl Diphosphate Synthases 1 item
  103. HIV Integrases 1 item
  104. Melatonin Receptors 1 item
  105. Peroxynitrite 1 item
  106. MAGL 1 item
  107. NPY Receptors 1 item
  108. c-Fyn 1 item
  109. Histamine H1 Receptors 3 items
  110. RAR/RXR 1 item
  111. TRP Channel 1 item
  112. DYRK 1 item
  113. Apoptosis Inducers 1 item
  114. MNK 1 item
  115. NO Donors / Precursors 1 item
  116. Glucocorticoid Receptors 1 item
  117. IL Receptors 1 item
  118. 15-lipoxygenases 1 item
  119. Inward Rectifier Potassium (Kir) Channels 2 items
  120. Peptidoglycan synthesis 1 item
  121. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  122. NMDA receptor 1 item
  123. Aldosterone receptor 1 item
  124. RNA synthesis 1 item
  125. BACE 1 item
  126. DPP-4 1 item
  127. DREADD Ligands 1 item
  128. p70 rsk 2 items
  129. Microtubule/Tubulin 2 items
  130. p53-MDM2 interaction 1 item
  131. KDR 1 item
  132. p53 3 items
  133. c-Fms tyrosine kinase 1 item
  134. insulin 1 item
  135. Ub-conjugating enzyme (E2) complex 1 item
  136. Smoothened receptor 1 item
  137. PPAR 1 item
  138. HDM2 ubiquitin ligase 1 item
  139. Glucosidases 1 item
  140. Vitamin D receptors (VDRs) 1 item
  141. Antibiotic 1 item
  142. DNA Alkylating 1 item
  143. GLI 1 item
  144. Stem Cell Differentiation 1 item
  145. PP2A/Nkd interaction 1 item
  146. adrenergic receptor 1 item
  147. Prk 1 item
  148. Ribonucleotide Reductases 1 item
  149. Rho 1 item
  150. Aryl hydrocarbon receptors (AHRs) 1 item
  151. DCLK2 1 item
  152. phosphatidylinositol kinase 1 item
  153. Lck 1 item
  154. Adenosine Deaminases 1 item
  155. Histamine receptors 1 item
  156. GluR 1 item
  157. 5-HT receptor 1 item
  158. dopamine receptors 1 item
  159. AMPA receptor 1 item
  160. Flk1 1 item
  161. p21 1 item
  162. RHA 1 item
  163. TRPC channel 1 item
  164. FKBP 1 item
  165. Bcl-w 1 item
  166. PPK 1 item
  167. c-Syk 1 item
  168. CDK1/CyclinB 1 item
  169. glucose uptake 1 item
  170. FXR 1 item
  171. Vascular Disrupting Agents (VDA) 1 item
  172. ATM 1 item
  173. Sirtuin 1 item
  174. PIKfyve 1 item
  175. Bax 1 item
  176. NS3/4a Proteases 1 item
  177. p90 S6K 1 item
Reported Experiments
  1. Animal Experiments 28 items
  2. Cell Experiments 24 items
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Breast Cancer 3 items
  3. Cancer 20 items
  4. Cholangiocarcinoma 1 item
  5. Chronic Lymphocytic Leukemia 1 item
  6. Colon Cancer 2 items
  7. Colorectal Cancer 2 items
  8. Glioblastoma 1 item
  9. Glioma 2 items
  10. Hepatocellular Carcinoma 1 item
  11. Liver Cancer 1 item
  12. Lung Cancer 1 item
  13. Melanoma 5 items
  14. Neuroblastoma 1 item
  15. Ovarian Cancer 1 item
  16. Pancreatic Cancer 1 item
  17. Prostate Cancer 2 items
  18. Renal Cancer 1 item
  19. Rheumatoid Arthritis 1 item
  20. Thyroid Cancer 2 items